This is a scale-to-quality
rerating case, not a moonshot. If Lemonade keeps compounding premium, cross-sells more households, and proves automation is lowering service cost and claims friction, investors can pay a better insurer multiple. The upside is meaningful because share gains can stay strong from a tiny base, but regulators,
reinsurance, and renewal shopping keep it from earning a software-style valuation.